During the first five years after the menopause, women lose approximately 30% of their dermal collagen. This is not an estimate: it is data measured in skin biopsies published in longitudinal studies. This dramatic decline explains why skin changes so visibly at this stage—more lines, less firmness, slower wound healing—and why intervening during this window is critical. The good news: understanding the hormonal-structural mechanism behind this loss allows you to make informed decisions, not marketing-based ones. In this article, you will see what triggers collagen degradation when oestrogen levels fall, what the evidence says about oral supplementation, which doses work and how to choose a supplement with scientific rigour.
The fall in oestrogen after the menopause accelerates the degradation of type I collagen in the dermis by up to 30% in the first 5 years
::
- You lose ~2% of dermal collagen per year after the menopause, 15 times faster than before
- Oestrogens directly regulate fibroblasts that produce type I and III collagen
- Supplementation with 10g daily of type I+III hydrolysed collagen improves density and elasticity in controlled studies
- Vitamin C as a cofactor is mandatory for endogenous synthesis; without it, oral collagen does not convert into structure
- The critical window is the first 5 years: intervening there makes a difference long-term
What is collagen and why the menopause destroys it
Collagen is the most abundant structural protein in your body: it represents 75% of your skin's dry weight. In the dermis (middle layer), fibroblasts primarily produce type I collagen (80%) and type III (15%), forming a three-dimensional network that provides firmness, elasticity and the ability to retain water.
Until the menopause, the balance between collagen synthesis and degradation remains relatively stable thanks to oestrogens, which act as metabolic regulators. But when ovarian oestradiol production falls—from ~100-200 pg/mL to <20 pg/mL over a few years—that balance breaks down brutally.
Oestrogens do not merely 'help' collagen: they control it directly. Dermal fibroblasts have oestrogen receptor alpha (ER-α) and beta (ER-β). When oestradiol binds to these receptors, it activates transcription of genes encoding procollagen type I and III. Without oestrogens, production falls. Simultaneously, the activity of matrix metalloproteinases (MMP-1, MMP-3) increases—enzymes that degrade existing collagen.
The result: you lose collagen from both directions—you produce less and destroy more.
Why your skin loses 30% of collagen in 5 years after the menopause
The fall in oestrogen triggers a cascade of metabolic changes that accelerate the degradation of type I and III collagen. A study published in American Journal of Clinical Dermatology measured dermal thickness and collagen density in skin biopsies from premenopausal and postmenopausal women: the annual loss of type I collagen is ~2% after the menopause, compared with 0.1–0.3% during reproductive years.
In the first five years, the rate is at its maximum. It then slows down, but the accumulated structural damage marks the difference between skin that maintains dermal thickness and skin that visibly thins.
The three concrete mechanisms are:
- Less synthesis: without oestrogen signalling, fibroblasts slow down procollagen production. In vitro studies show that human fibroblasts cultured with oestradiol synthesise 40% more type I collagen than controls without the hormone.
- More degradation: metalloproteinases (MMP-1, MMP-3, MMP-9) increase their activity when oestrogen levels fall. These enzymes break down existing collagen fibres into fragments that are then eliminated. Recent meta-analyses show that MMP-1 expression in postmenopausal skin is 2–3 times higher than in premenopausal skin.
- Low-grade chronic inflammation: the fall in oestrogen raises systemic inflammatory markers (IL-6, TNF-α) that also activate MMPs and slow collagen synthesis. It is a self-reinforcing loop.
The visible result: fine lines become deep wrinkles, skin loses bounce (elasticity), wounds take longer to heal and texture becomes finer and more fragile. It is not just about aesthetics—/en/skin-reflects-biological-age shows correlation between dermal thickness and systemic markers of ageing.
Benefits of collagen supplementation during the menopause: what the evidence says
Oral supplementation with type I+III hydrolysed collagen shows measurable effects on dermal density, elasticity and hydration in controlled trials with postmenopausal women. It is not magic: the bioactive peptides (fragments of 2–10 amino acids) resulting from enzymatic hydrolysis of collagen are absorbed intact, reach the dermis via the bloodstream and act as signals that stimulate resident fibroblasts.
Key study (2021, Journal of Cosmetic Dermatology): 106 postmenopausal women (50–65 years) received 10g daily of type I+III collagen peptides or placebo for 12 weeks. The collagen group showed:
- +12% dermal collagen density measured by high-frequency ultrasound
- +9% skin elasticity (cutometry)
- Significant reduction in periorbital wrinkle depth (−15% vs placebo)
Proposed mechanism: bioactive peptides (especially proline-hydroxyproline and hydroxyproline-glycine) act as ligands on fibroblast cell membrane receptors, activating signalling cascades that:
- Increase expression of COL1A1 and COL3A1 genes (codes for type I and III collagen)
- Reduce activity of MMP-1 and MMP-3 (less degradation)
- Stimulate endogenous hyaluronic acid synthesis, improving hydration
Recent meta-analyses (11 trials, n=805 women) conclude that doses ≥10g/day for ≥8 weeks produce measurable and statistically significant effects on elasticity and dermal density. Lower doses (2.5–5g) show inconsistent results.
Recommended dosage and how to take collagen during the menopause
The effective dose in studies with postmenopausal women is 10 grams daily of type I+III hydrolysed collagen, taken continuously for at least 8–12 weeks to see measurable changes.
Optimal format: hydrolysed collagen (bioactive peptides), not gelatine or native collagen. Enzymatic hydrolysis breaks down the collagen triple helix into small fragments that are absorbed intact. Bioavailability studies show that peptides of 2–10 amino acids cross the intestinal barrier and appear in plasma 1–2 hours post-intake, accumulating in the dermis over 48–96 hours.
Timing of intake: irrelevant (morning, evening, with or without food). What matters is consistency, not timing.
Mandatory cofactor: vitamin C. Without vitamin C, your body cannot convert proline into hydroxyproline or synthesise functional collagen. The prolyl hydroxylase enzyme requires ascorbic acid as a cofactor. Studies show that supplementing collagen without vitamin C reduces effectiveness by up to 40%. /en/vitamin-c-collagen-cofactor explains the mechanism in detail.
Practical protocol for women in the menopause:
- 10g type I+III hydrolysed collagen (verified peptides, no added sugars)
- 100–500mg vitamin C (liposomal for improved absorption)
- Consistency >8 weeks before evaluating results
- Optional: 120mg oral hyaluronic acid (studies show synergy with collagen in dermal hydration)
Do not expect changes in 1–2 weeks. The renewal of dermal collagen is slow—fibroblasts need time to synthesise, assemble and deposit new fibres. Studies measure effects from week 8–12 onwards.
How to choose a good collagen supplement (and avoid marketing hype)
The collagen market is saturated with products making exaggerated claims, insufficient doses and questionable formats. This is what you should verify before buying:
1. Type of collagen: should specify type I+III hydrolysed (bioactive peptides). If it only says 'marine collagen' or 'bovine collagen' without mentioning hydrolysis or type, avoid it. /en/hydrolysed-collagen-which-type breaks down the differences.
2. Dose per serving: minimum 10g of hydrolysed collagen per portion. Products with 2–5g/day do not reach the effective dose found in studies.
3. Vitamin C cofactor: should include at least 100mg of vitamin C in bioavailable form (liposomal is superior to basic ascorbic acid). Without this, you waste the collagen.
4. No added sugars or artificial sweeteners. Many 'flavoured' collagen products contain 8–15g of sugar per serving—counterproductive for inflammation and glycation (damage to existing collagen by sugars).
5. Traceability and certification. Should specify collagen source (grass-fed bovine, wild-caught marine) and have purity certifications (no heavy metals, no contaminants).
LongeviSkin meets these criteria: it combines 10g daily of type I+III hydrolysed collagen in verified bioactive peptide format, liposomal vitamin C as the mandatory cofactor for endogenous synthesis, and 120mg of oral hyaluronic acid. No sugars, no flavourings, no marketing extracts. Designed specifically for the metabolic window of the menopause, when intervention makes the greatest difference.
If you prefer another brand, verify that it meets the 5 points above. And remember: /en/oral-hyaluronic-acid-works shows synergy with collagen in dermal hydration studies—it is not mandatory, but it potentiates results.
Side effects and contraindications of oral collagen
Type I+III hydrolysed collagen is extremely safe—it is simply pre-digested protein. Human safety studies (10–20g/day doses for 12 months) report no significant adverse effects.
Occasional minor effects:
- Mild digestive discomfort (sense of fullness, gas) in <5% of users, especially with initial doses. Taking with food reduces incidence.
- Residual taste if the product is not well formulated (more common in unprocessed marine collagen).
Contraindications:
- Known allergy to source (fish if marine collagen, bovine if from beef). If you have a fish allergy, use bovine collagen; if you are allergic to beef protein, use marine.
- Advanced kidney disease: consult your nephrologist before supplementing with high doses of protein (10g collagen = 10g additional protein).
- Hypercalcaemia or calcium kidney stones: some marine collagens have calcium residues. Check composition.
Drug interactions: no significant interactions are reported with common medications (antihypertensives, statins, levothyroxine, HRT). But if you are taking hormone replacement therapy (HRT), consult your doctor—the combination HRT + oral collagen may potentiate effects on skin, but requires supervision.
Can oral collagen 'replace' HRT? No. Collagen acts at the structural level—it provides amino acids and signals to stimulate fibroblasts. HRT acts at the systemic hormonal level, regulating oestrogen receptors in multiple tissues (bone, brain, cardiovascular, skin). They are complementary, not substitutes.
Frequently asked questions about collagen and the menopause
When should I start taking collagen if I am in perimenopause?
The critical window is the first 5 years after your last menstrual period, when collagen loss is fastest. But starting in perimenopause (when cycles become irregular and oestrogen levels fluctuate) can cushion the fall. No studies define 'the optimal time', but intervening before degradation becomes massive has biological logic.
Does oral collagen really reach the skin or is it destroyed in the stomach?
Yes, it reaches it. Isotope-labelled studies with traced collagen (C14) show that bioactive peptides of 2–10 amino acids are absorbed intact in the intestine, appear in plasma and accumulate in the dermis over 48–96 hours. They are not completely 'destroyed'—the enzymatic hydrolysis process beforehand (during manufacture) pre-digests the collagen, allowing direct absorption of functional fragments.
Can I get the same effect from eating collagen-rich foods?
Foods such as bone broth, chicken skin or gelatine contain collagen, but in native (non-hydrolysed) form, which reduces absorption of bioactive peptides by up to 60% versus hydrolysed collagen. To reach 10g of absorbable peptides you would need impractical quantities of broth. Supplementing is more efficient if you seek measurable effects.
Does combining collagen with oral hyaluronic acid make sense?
Yes. Studies show synergy between collagen and oral hyaluronic acid in dermal hydration. Hyaluronic acid (120–240mg/day) is partially absorbed and stimulates endogenous hyaluronate synthesis in the dermis, improving water retention in the extracellular matrix. Together they optimise structure (collagen) and hydration (HA). /en/oral-hyaluronic-acid-works reviews the evidence.
Does collagen help with other menopause symptoms (hot flushes, insomnia)?
Not directly. Collagen acts at the dermal, joint and bone structural level, not on vasomotor symptoms or sleep regulation. For hot flushes, HRT has the most evidence. For insomnia, protocols such as magnesium glycinate and /en/how-to-sleep-better show efficacy. Collagen is one piece of the longevity puzzle during the menopause, not the complete solution.
Are the results permanent or do they disappear when I stop taking collagen?
The benefits persist while you maintain the stimulus. If you stop taking collagen, synthesis reverts to baseline levels (low in postmenopause) and degradation continues. Longitudinal studies show that stopping supplementation after 12 weeks leads to gradual loss of improvements in elasticity over the following 2–3 months. To maintain results, supplementation should be continuous or cyclical (12 weeks on, 4 off, repeat).
Conclusion: collagen in the menopause is an evidence-based intervention
The fall in oestrogen after the menopause accelerates dermal collagen loss to ~2% annually, accumulating to 30% in five years. This structural change explains visible skin ageing at that stage—it is not inevitable, but it requires active intervention.
Supplementation with 10g daily of type I+III hydrolysed collagen, combined with vitamin C as a cofactor, shows measurable effects on dermal density, elasticity and wrinkle depth in controlled trials with postmenopausal women. It is not luxury cosmetics or marketing—it is biochemistry: you provide specific amino acids and signals that stimulate resident fibroblasts when endogenous production falls.
The key is consistency (minimum 8–12 weeks), the correct dose (10g, not 2–5g), the presence of cofactors (vitamin C is mandatory) and choosing a verified hydrolysed format. The critical window is the first five years post-menopause, but intervening at any point in postmenopause remains useful.
And remember: collagen is one piece of an integrated longevity protocol that includes quality deep sleep, inflammation control, strength training (which stimulates type I collagen synthesis in tendons and skin) and anti-inflammatory nutrition. There are no magic bullets, but there are evidence-based interventions that add up.
Disclaimer: This information is for educational purposes and does not replace professional medical advice. Consult your doctor before beginning any supplementation protocol, especially if you take medication (including hormone replacement therapy), have pre-existing conditions (renal, hepatic, autoimmune) or are under cancer treatment. Collagen is a food supplement, not a medicine, and is not designed to diagnose, treat, cure or prevent any disease.
